Bringing the 'sticky' back to pancreatic cancer

Bringing the 'sticky' back to pancreatic cancer
BACH1 reduces cell-to-cell adhesion in pancreatic cancer cells, promoting their spread to other parts of the body, like the liver. Credit: Tohoku University

A multidisciplinary team of researchers at Japan's Tohoku University has found that a gene regulator, called BACH1, facilitates the spread of pancreatic cancer to other parts of the body. The scientists, who published their findings in the journal Cancer Research, say drugs that control BACH1 could improve disease prognosis.

"Pancreatic is a malignant disease with one of the poorest prognoses," says biochemist Kazuhiko Igarashi, who led the study. "One of the reasons for this is that cells undergo rapid, profound metastasis to other organs, like the liver. We found out how pancreatic cancer cells acquire this ability for metastasis."

Igarashi, surgeon-scientist Michiaki Unno and their team investigated the effects of silencing and over-expressing the BACH1 transcription factor in pancreatic cancer cells. Previous studies had already identified a role for this in promoting breast cancer metastasis. But its role in pancreatic cancer was unknown. The team also grafted pancreatic cancer cells with and without the BACH1 gene disruption into mice. Finally, they studied BACH1 protein levels in human pancreatic cancer tissues and compared them to their survival rates.

Their investigations showed that BACH1 reduces the expression of some involved in cell-to-cell interaction, and enhances the expression of others that cause cells to lose their 'stickiness' to each other, making them more mobile and invasive.

For example, BACH1 was found to play a role in repressing the gene FOXA1 and activating the gene SNAI2, which ultimately leads to the suppression of a gene called CDH1. This gene codes for a protein called E-cadherin, one of the most important cell surface molecules involved in cell-to-cell adhesion.

"By reducing or abolishing BACH1 activity, the metastatic potential of pancreatic cancer cells was greatly reduced in a ," adds Igarashi. "We also found that patients at Tohoku University Hospital showed poorer prognoses when their pancreatic cancer cells expressed higher levels of BACH1."

Further investigations into BACH1's roles in pancreatic cancer metastasis could lead to the development of therapeutic strategies that reduce metastasis and thus improve the prognosis for people with pancreatic cancer, Igarashi explains.

The team next plans to look for other genes targeted by BACH1 in pancreatic cancer cells, which could have effects other than promoting metastasis.


Explore further

Study pinpoints gene's role in pancreatic cancer

More information: Masaki Sato et al. BACH1 promotes pancreatic cancer metastasis by repressing epithelial genes and enhancing epithelial-mesenchymal transition. Cancer Research DOI: 10.1158/008-5472.CAN-18-4099
Journal information: Cancer Research

Provided by Tohoku University
Citation: Bringing the 'sticky' back to pancreatic cancer (2020, February 3) retrieved 14 July 2020 from https://medicalxpress.com/news/2020-02-sticky-pancreatic-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments